SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-042354
Filing Date
2022-02-15
Accepted
2022-02-14 18:19:13
Documents
2
Group Members
STEVEN BOYD

Document Format Files

Seq Description Document Type Size
1 SC 13G d333668dsc13g.htm SC 13G 65090
2 EXHIBIT 99.1 d333668dex991.htm EX-99.1 2857
  Complete submission text file 0001193125-22-042354.txt   69743
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Subject) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48089 | Film No.: 22635723
SIC: 7389 Services-Business Services, NEC

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G